Dec 31, 2025 • openPR.com
SOMEWHAT-BULLISH
Japan Nucleic Acid Isolation and Purification Market is Driven by Biotech Research and Genomic Advancements | Top Companies - MP Biomedicals, Illumina Inc., General Electric Company
The Japan Nucleic Acid Isolation and Purification Market is projected to grow at a CAGR of 4.8% from 2024 to 2031, driven by advancements in biotech research and genomics. Key market players include MP Biomedicals, Illumina Inc., and General Electric Company. Recent industry developments in Japan highlight innovations in rapid viral RNA extraction, automated nucleic acid isolation, magnetic bead kits for mRNA vaccine QC, and customization centers for extraction reagents.
Dec 27, 2025 • MarketBeat
SOMEWHAT-BULLISH
Pacer Advisors Inc. Acquires New Position in Illumina, Inc. $ILMN
Pacer Advisors Inc. has acquired a new position in Illumina, Inc. (NASDAQ:ILMN), purchasing 649,290 shares valued at approximately $61.66 million in the third quarter. This represents about 0.42% ownership of the life sciences company. Illumina recently surpassed quarterly earnings expectations with $1.34 EPS and $1.08 billion in revenue, and has set its FY2025 guidance at 4.650-4.750 EPS.
Dec 26, 2025 • MarketBeat
SOMEWHAT-BULLISH
Voya Investment Management LLC Has $5.23 Million Stock Holdings in Illumina, Inc. $ILMN
Voya Investment Management LLC decreased its stake in Illumina, Inc. by 32.8% in Q3, holding 55,027 shares valued at $5.23 million. Illumina surpassed Q3 earnings estimates with $1.34 EPS and $1.08 billion in revenue, prompting analysts to raise price targets, though the consensus remains a "Hold" with an average target of $118.31. Institutional investors collectively own approximately 89.4% of the company's stock.
Dec 25, 2025 • MarketBeat
SOMEWHAT-BULLISH
Swedbank AB Grows Position in Illumina, Inc. $ILMN
Swedbank AB significantly increased its stake in Illumina, Inc. (NASDAQ:ILMN) during the third quarter, raising its total holdings to 825,491 shares valued at approximately $78.4 million. This move comes as institutional investors now own 89.42% of the stock, alongside notable insider transactions including a director's purchase and another insider's sale. Illumina generally beat Q3 earnings expectations and carries a consensus "Hold" rating from analysts.
Dec 24, 2025 • MarketBeat
SOMEWHAT-BULLISH
Insiders Are Selling Illumina, Inc. (NASDAQ:ILMN) Stock
Assenagon Asset Management S.A. significantly reduced its holdings in Illumina, Inc. (NASDAQ:ILMN) by 91.7% in the third quarter. Despite this, Illumina reported strong Q3 earnings, beating expectations, and provided optimistic FY2025 guidance. The stock is currently trading up, with institutional investors owning a substantial portion of shares, though analyst ratings are mixed with a "Hold" consensus.
Dec 24, 2025 • Sahm
SOMEWHAT-BEARISH
Is Illumina Inc Gaining or Losing Market Support?
Illumina Inc (NYSE: ILMN) has seen a 7.9% increase in its short interest as a percentage of float, now standing at 6.83% of all available shares for trading. This increase signals a potentially more bearish market sentiment towards the stock by some investors. Despite this, Illumina's short interest is still lower than the peer group average of 7.44%.